Antigen binding regions against fibronectin type III domains and methods of using the same
US-12269870-B2 · Apr 8, 2025 · US
This page is not indexed by search engines while we improve data quality.
Naso Michael patents
Naso Michael is listed as an inventor on 27 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Naso Michael |
| Total patents | 27 |
| First publication | Mar 10, 2015 |
| Latest publication | Apr 8, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Antigen Binding Regions Against Fibronectin Type III Domains and Methods of Using the Same
US-2022127343-A1 · Apr 28, 2022 · US
Chimeric antigen receptors comprising bcma-specific fibronectin type iii domains and uses thereof
US-2022031822-A1 · Feb 3, 2022 · US
Antigen binding regions against fibronectin type III domains and methods of using the same
US-11161897-B2 · Nov 2, 2021 · US
Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereof
US-11096998-B2 · Aug 24, 2021 · US
Novel aav mediated influenza vaccines
US-2020390888-A1 · Dec 17, 2020 · US
Immortalized car-t cells genetically modified to eliminate t-cell receptor and beta 2-microglobulin expression
US-2020332255-A1 · Oct 22, 2020 · US
AAV mediated influenza vaccines
US-10786568-B2 · Sep 29, 2020 · US
Chimeric Antigen Receptors Comprising BCMA-specific Fibronectin Type III Domains and Uses Thereof
US-2019330361-A1 · Oct 31, 2019 · US
ST2L antagonists and methods of use
US-10450377-B2 · Oct 22, 2019 · US
Recent patents
Latest publications not already listed above.
Immortalized car-t cells genetically modified to elminate t-cell receptor and beta 2-microglobulin expression
US-2019175651-A1 · Jun 13, 2019 · US
St2l antagonists and methods of use
US-2019062439-A1 · Feb 28, 2019 · US
Antigen Binding Regions Against Fibronectin Type III Domains and Methods of Using The Same
US-2019016789-A1 · Jan 17, 2019 · US
Novel aav mediated influenza vaccines
US-2018243416-A1 · Aug 30, 2018 · US
ST2L antagonists and methods of use
US-9951137-B2 · Apr 24, 2018 · US
Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1 (IGF-1)
US-2018016340-A1 · Jan 18, 2018 · US
Anti-tissue factor antibodies and compositions
US-9708410-B2 · Jul 18, 2017 · US
ST2L Antagonists and Methods of Use
US-2017066831-A1 · Mar 9, 2017 · US
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)
US-9587024-B2 · Mar 7, 2017 · US
Anti-tissue factor antibodies and compositions
US-2016194405-A1 · Jul 7, 2016 · US
ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
US-9212227-B2 · Dec 15, 2015 · US
Methods and Vectors for Generating Asialylated Immunoglobulins
US-2015291946-A1 · Oct 15, 2015 · US
Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor I (IGF-1)
US-2015259422-A1 · Sep 17, 2015 · US
ST2L antibody antagonists
US-9090694-B2 · Jul 28, 2015 · US
Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)
US-9073996-B2 · Jul 7, 2015 · US
Macaca fascicularis CCL17
US-9012602-B2 · Apr 21, 2015 · US
Methods and vectors for generating asialylated immunoglobulins
US-8975040-B2 · Mar 10, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Janssen Biotech Inc | 23 |
| Univ Pennsylvania | 3 |
| Univ North Carolina | 2 |
| Univ North Carolina Chapel Hill | 2 |
| Naso Michael | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/92 | 15 |
| C07K2317/565 | 14 |
| A61P35/00 | 13 |
| C07K2317/76 | 12 |
| A61K2039/505 | 11 |